Jason Fleming

8PUBLICATIONS
134CO-AUTHORS
Pacific Peoples and disabilityMolecular targetsCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 24, 2025
The Impact of Edema on Skeletal Muscle Changes among Patients with Pancreatic Ductal Adenocarcinoma.

Evan W Davis, Margaret A Park, Toni L Basinski

|May 29, 2025
SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition.

Gilbert Z Murimwa, Natalie E Williams, Dina Alzhanova

|Mar 24, 2025
Colorectal Tumors in Diverse Patient Populations Feature a Spectrum of Somatic Mutational Profiles.

Marco Matejcic, Jamie K Teer, Hannah J Hoehn

|Dec 05, 2023
Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived Tumors.

Aslamuzzaman Kazi, Alok Ranjan, Vasantha Kumar M V

|Jul 11, 2021
Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway.

Bingbing Dai, Jithesh J Augustine, Ya'an Kang

|Jan 28, 2021
A Mathematical Model to Estimate Chemotherapy Concentration at the Tumor-Site and Predict Therapy Response in Colorectal Cancer Patients with Liver Metastases.

Daniel A Anaya, Prashant Dogra, Zhihui Wang

Pageof 2

Frequent Collaborators

2 joint publications

Kun Jiang

2 joint publications

Alexandra F Tassielli

2 joint publications

Jamie K Teer

2 joint publications

Jose Trevino